North America dominates the global cardiovascular drugs market. This is due to increased awareness about various heart diseases in the region. The U.S. represents the largest market for cardiovascular drugs followed by Canada in North America. In Europe, Germany, the U.K., Spain, Italy and France holds major share of cardiovascular drugs market. However, Asia is expected to show high growth rates in the next five years in global cardiovascular drugs market. This is due to many companies constructing their R&D facilities in the region. Less stringent wages and availability of skilled labour attracts manufacturing companies to invest in Asia. In addition, increasing awareness about heart related problems is also supporting in the growth of cardiovascular drugs market in the region. Japan, China and India are expected to be the fastest growing cardiovascular drug markets in Asia.
Read More:
https://knackersblogger.blogspot.com/2022/06/cardiovascular-drugs-market-global.html
